Effect of Genistein on Endometriosis Lesion, Matrix Metalloproteinase-2 and -9 Level of Endometriosis: In silico and In vivo Study

Maharani Maharani, Endang Sri Wahyuni, Sutrisno Sutrisno
In: Journal of Clinical and Molecular Endocrinology · 2016 · vol. 1(1) · W2501404495
Lab / animal OA: closed CC0 ⤵ 3 in-corpus citations Metadata only
View on OpenAlex
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-06-08 ⓘ

This study found that genistein treatment in a mouse model of endometriosis reduced lesion size and significantly attenuated the elevated levels of MMP-2 and MMP-9.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

This in silico and in vivo investigation were to know the effect of genistein on alteration of MMPs in a mice model of endometriosis. Forty female mice (Mus musculus) were divided into eight groups (n=5 each), including the control (untreated) group, endometriosis group, and the endometriosis (EM) groups were given various doses of genistein (at dose of 50; 100; 200; 300; 400; 500 mg/day). In silico analysis was performed using Open Babel, 3D DART webserver, HEX software, and NUCPLOT software. Analysis of MMP-2 and MMP-9 level were done by enzyme linked immuno sorbent assay (ELISA) technically. In the absence of genistein, ΣE total required for the interaction between NF-?B with MMP-2 or MMP-9 gene promoter were increased in genistein treatment (-2393.71 kJ/mol and -2393.86 kJ/mol) compared with no genistein treatment (-2415.62 kJ/mol and -2457.00 kJ/mol). In endometriosis group we were founded the massive endometriosis lesion and hyper vascularization. All doses the treatment with genistein reduces the size of endometriosis lesion. The level of MMP-2 and MMP-9 was significantly higher in the EM group compared to the untreated control group (P<0.05). This increase in MMP-2 was significantly (P<0.05) attenuated by all doses of genistein. These increased levels of MMP-9 in the EM group were significantly reduced by 100 mg/day administration of genistein. In conclusion, genistein prohibits the increase in MMP-2 and MMP-9 in a mice model of endometriosis. Therefore, this may provide a natural therapy for attenuating the alteration of MMPs found in endometriosis disease.

My notes (saved in your browser only)

Condition tags

endometriosis

Citation neighborhood (2-hop)

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]

References (33)

Cited by (3)

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0 · commercial use OK